Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week pediatric asthma study of fluticasone propionate MDPI versus fluticasone propionate + salmeterol MDPI with placebo control
2016-003835-39Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in persistent asthma and asthma comparing Fluticasone propionate MDPI, Fluticasone propionate + salmeterol MDPI and Placebo (3 arms). Started Feb 2017; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
persistent asthmaasthma
Beyond the preview
Go deeper on 2016-003835-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003835-39.